Rchr
J-GLOBAL ID:201301084754380900
Update date: Feb. 01, 2024
HANYU Masayuki
ハニユウ マサユキ | HANYU Masayuki
Affiliation and department:
Homepage URL (1):
http://kaken.nii.ac.jp/d/r/80435552.ja.html
Research field (2):
Radiology
, Chemical biology
Research keywords (1):
PET薬剤合成・標識合成・ペプチド合成
Research theme for competitive and other funds (6):
- 2021 - 2025 Stapled peptide-based radiotheranostics for intracellular protein-protein interactions targeted cancer imaging and therapy
- 2021 - 2024 キレーター含有糖ユニットで修飾した抗体の標識反応と評価
- 2021 - 2024 mGluR1を標的とするα線Radio-theranosticsシステムの確立
- 2018 - 2021 膵がん細胞を特異的に認識する放射性ナノ金属薬剤の合成および評価
- 2014 - 2017 Radiosynthesis and evaluation of tumor cell-penetrating oligopeptides containing short-lived positron-emitt ing radionuclides
- 2012 - 2014 Radiosynthesis and evaluation of peptide probe containing short-lived positron-emitting radionuclides via a Pictet-Spengler reaction
Show all
Papers (30):
-
Lin Xie, Lulu Zhang, Kuan Hu, Masayuki Hanyu, Yiding Zhang, Masayuki Fujinaga, Katsuyuki Minegishi, Takayuki Ohkubo, Kotaro Nagatsu, Cuiping Jiang, et al. A 211At-labelled mGluR1 inhibitor induces cancer senescence to elicit long-lasting anti-tumor efficacy. Cell reports. Medicine. 2023. 4. 4. 100960-100960
-
Kazunori Kawamura, Hiroki Hashimoto, Takayuki Ohkubo, Masayuki Hanyu, Masanao Ogawa, Nobuki Nengaki, Daisuke Arashi, Yusuke Kurihara, Tomoya Fujishiro, Takahiro Togashi, et al. Automated radiosynthesis of [11 C]MTP38-a phosphodiesterase 7 imaging tracer-using [11 C]hydrogen cyanide for clinical applications. Journal of labelled compounds & radiopharmaceuticals. 2022. 65. 5. 140-146
-
Kuan Hu, Xiaohui Ma, Lin Xie, Yiding Zhang, Masayuki Hanyu, Honoka Obata, Lulu Zhang, Kotaro Nagatsu, Hisashi Suzuki, Rui Shi, et al. Development of a Stable Peptide-Based PET Tracer for Detecting CD133-Expressing Cancer Cells. ACS omega. 2022. 7. 1. 334-341
-
Kuan Hu, Wenyu Wu, Lin Xie, Hao Geng, Yiding Zhang, Masayuki Hanyu, Lulu Zhang, Yinghuan Liu, Kotaro Nagatsu, Hisashi Suzuki, et al. Whole-body PET tracking of a D-dodecapeptide and its radiotheranostic potential for PD-L1 overexpressing tumors. Acta Pharmaceutica Sinica B. 2021
-
Xiumin Shi, Qing Li, Lulu Zhang, Masayuki Hanyu, Lin Xie, Kuan Hu, Kotaro Nagatsu, Chuan Zhang, Zhengcan Wu, Feng Wang, et al. 211At-Labeled Polymer Nanoparticles for Targeted Radionuclide Therapy of Glucose-Dependent Insulinotropic Polypeptide Receptor (GIPR)-Overexpressed Cancer. Bioconjugate chemistry. 2021. 32. 8. 1763-1772
more...
MISC (19):
-
Kuan Hu, Jingjie Shang, Lin Xie, Masayuki Hanyu, Yiding Zhang, Zhimin Yang, Zhimin Yang, Hao Xu, Lu Wang, Ming-Rong Zhang. Positron Emission Tomography Imaging of Vascular Endothelial Growth Factor Receptor Expression with a new Cu-64 labeled peptide. JOURNAL OF NUCLEAR MEDICINE. 2020. 61
-
Masayuki Hanyu, Hideki Ishii, Nobuki Nengaki, Masanao Ogawa, Daisuke Arashi, Kenji Furutsuka, Hiroki Hashimoto, Kazunori Kawamura, Ming-Rong Zhang. Measurement of the metal impurity in PET probe using the HPLC post-column method. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS. 2019. 62. S580-S580
-
Kuan Hu, Ming-Rong Zhang, Masayuki Hanyu, Lin Xie, Yiding Zhang. Develop a peptide-based PET radiotracer for imaging PD-L1 expression in cancer. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS. 2019. 62. S46-S47
-
Kuan Hu, Ming-Rong Zhang, Masayuki Hanyu, Lin Xie, Yiding Zhang. Peptide modified and radiometals loaded BP quantum dots for targeted PET imaging-guided tumor photothermal and photodynamic therapy. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS. 2019. 62. S366-S367
-
東梨佳子, 東梨佳子, 馬立秋, 馬立秋, 坂本慶充, 坂本慶充, 金井昭教, 謝琳, 破入正行, 張明栄, et al. 炭素イオン線と免疫療法併用によるabscopal効果の誘導. 日本放射線影響学会大会抄録(Web). 2017. 60th. 141-141
more...
Patents (3):
Professional career (1):
Work history (7):
Return to Previous Page